These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro exposure to paclitaxel modulates integrin expression by human T lymphocytes and inhibits T cell adhesion to breast carcinoma cells. Bhan V, Mader JS, Hoskin DW. Oncol Rep; 2004 Apr; 11(4):893-7. PubMed ID: 15010891 [Abstract] [Full Text] [Related]
3. Tiazofurin induces a down-modulation of ICAM-1 expression on K562 target cells impairing NK adhesion and killing. Zamai L, Zauli G, Bavelloni A, Marmiroli S, Cataldi A, Weber G, Vitale M. Cell Immunol; 1995 Aug; 164(1):100-4. PubMed ID: 7543370 [Abstract] [Full Text] [Related]
10. Non-cytotoxic and sublethal paclitaxel treatment potentiates the sensitivity of cultured ovarian tumor SKOV-3 cells to lysis by lymphokine-activated killer cells. Law KS, Chen HC, Liao SK. Anticancer Res; 2007 Mar; 27(2):841-50. PubMed ID: 17465210 [Abstract] [Full Text] [Related]
11. The correlation between the percent of CD3- CD56+ cells and NK precursor function. Gharehbaghian A, Donaldson C, Newman J, Bannister G, Bradley BA. Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):167-75. PubMed ID: 17237569 [Abstract] [Full Text] [Related]
12. Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125. Patankar MS, Jing Y, Morrison JC, Belisle JA, Lattanzio FA, Deng Y, Wong NK, Morris HR, Dell A, Clark GF. Gynecol Oncol; 2005 Dec; 99(3):704-13. PubMed ID: 16126266 [Abstract] [Full Text] [Related]
13. Lymphocyte binding to K562 cells: effect of target cell irradiation and correlation with ICAM-1 and LFA-3 expression. Zamai L, Rana R, Mazzotti G, Centurione L, Di Pietro R, Vitale M. Eur J Histochem; 1994 Dec; 38 Suppl 1():53-60. PubMed ID: 8547711 [Abstract] [Full Text] [Related]
14. A novel immunomodulatory mechanism of ribavirin in suppressing natural killer cell function. Ogbomo H, Michaelis M, Altenbrandt B, Doerr HW, Cinatl J. Biochem Pharmacol; 2010 Jan 15; 79(2):188-97. PubMed ID: 19665449 [Abstract] [Full Text] [Related]
15. CD16 polymorphisms and NK activation induced by monoclonal antibody-coated target cells. Bowles JA, Weiner GJ. J Immunol Methods; 2005 Sep 15; 304(1-2):88-99. PubMed ID: 16109421 [Abstract] [Full Text] [Related]
16. Effect of irradiation-induced intercellular adhesion molecule-1 expression on natural killer cell-mediated cytotoxicity toward human cancer cells. Jeong JU, Uong TNT, Chung WK, Nam TK, Ahn SJ, Song JY, Kim SK, Shin DJ, Cho E, Kim KW, Cho D, Yoon MS. Cytotherapy; 2018 May 15; 20(5):715-727. PubMed ID: 29572116 [Abstract] [Full Text] [Related]
17. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity. Lilienfeld BG, Crew MD, Forte P, Baumann BC, Seebach JD. Xenotransplantation; 2007 Mar 15; 14(2):126-34. PubMed ID: 17381687 [Abstract] [Full Text] [Related]
18. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression. Song H, Kim J, Cosman D, Choi I. Cell Immunol; 2006 Jan 15; 239(1):22-30. PubMed ID: 16630603 [Abstract] [Full Text] [Related]
19. Occurrence and a possible mechanism of penetration of natural killer cells into K562 target cells during the cytotoxic interaction. Radosević K, van Leeuwen AM, Segers-Nolten IM, Figdor CG, de Grooth BG, Greve J. Cytometry; 1995 Aug 01; 20(4):273-80. PubMed ID: 7587714 [Abstract] [Full Text] [Related]
20. Exposure to paclitaxel or vinblastine down-regulates CD11a and CD54 expression by P815 mastocytoma cells and renders the tumor cells resistant to killing by nonspecific cytotoxic T lymphocytes induced with anti-CD3 antibody. Zhao C, Morgan M, Haeryfar SM, Blay J, Hoskin DW. Cancer Immunol Immunother; 2003 Mar 01; 52(3):185-93. PubMed ID: 12649748 [Abstract] [Full Text] [Related] Page: [Next] [New Search]